Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmarise HoldingsTSE:2796 -0.61%50 ROA % is 0.02% as of May. 2026, which is 91% below its 10-year median of 0.22. GuruFocus rates TSE:2796 with a GF Score™ of 50/100 and a GF Value™ of 円608.01 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Pharmarise Holdings ranks worse than 61.38% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Pharmarise Holdings's annualizedNet Income for the quarter that ended in May. 2026 was 円6 Mil.
Pharmarise Holdings's average Total Assets over the quarter that ended in May. 2026 was 円31,318 Mil. Therefore, Pharmarise Holdings's annualized ROA % for the quarter that ended in May. 2026 was 0.02%.
The historical rank and industry rank for Pharmarise Holdings's ROA % or its related term are showing as below:
TSE:2796'
s ROA % Range Over the Past 10 Years
Min: -1.33 Med: 0.22 Max: 2.33
Current: 0.36
During the past 13 years, Pharmarise Holdings's highest ROA % was 2.33%. The lowest was -1.33%. And the median was 0.22%.
TSE:2796's ROA % is ranked worse than 61.38% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.81
vs TSE:2796: 0.36
Pharmarise Holdings (TSE:2796) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (May. 2026) net income data. The Revenue data used here is two times the semi-annual (May. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Pharmarise Holdings ROA % Related Terms
Pharmarise Holdings ROA % Historical Data
* Premium members only.
The historical data trend for Pharmarise Holdings's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmarise Holdings ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's ROA % distribution charts can be found below:
* The bar in red indicates where Pharmarise Holdings's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (May. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Pharmarise Holdings (TSE:2796) has a ROA % of 0.02% as of May. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Pharmarise Holdings and its competitors. This is 91% below median its historical median of 0.22. According to the industry distribution chart, Pharmarise Holdings ranks #418 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 61.4%.
Is Pharmarise Holdings' ROA % too high?
Pharmarise Holdings' current ROA % of 0.02% is 91% below median its 10-year median of 0.22. The Healthcare Providers & Services industry median ROA % is 1.81. Pharmarise Holdings' value of 0.02% is 98.9% below this industry median. Based on the distribution chart, Pharmarise Holdings ranks #418 out of 681 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pharmarise Holdings has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharmarise Holdings' ROA % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pharmarise Holdings ranks #418 out of 681 companies for ROA %. This places Pharmarise Holdings in the lower half of its industry. The industry median ROA % is 1.81. Pharmarise Holdings' value of 0.02% is 98.9% below this benchmark. While the company's 10-year median is 0.22 vs. the industry median of 1.81, Pharmarise Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.81, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmarise Holdings's current ROA % of 0.02% is 98.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Pharmarise Holdings and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmarise Holdings's current ROA % is 0.02%, which is 91% below median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmarise Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pharmarise Holdings (TSE:2796) is currently considered Modestly Undervalued. The stock's GF Value™ is 円608.01, compared to a current price of 円491.00 — trading 19.2% below its estimated fair value. The current ROA % is 0.02%, which is 91% below median its 10-year median of 0.22 and 98.9% below the Healthcare Providers & Services industry median of 1.81. Pharmarise Holdings' overall GF Score™ is 50/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Pharmarise Holdings (TSE:2796), the current ROA % is 0.02% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmarise Holdings (TSE:2796) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmarise Holdings stock appears to be undervalued.
The current stock price of 円491.00 is trading 19.2% below its estimated GF Value™ of 円608.01.
GuruFocus considers Pharmarise Holdings to be Modestly Undervalued.
Key valuation signals for TSE:2796:
ROA %: 0.02% (91% below median its 10-year median of 0.22)
GF Value™: 円608.01 vs. price of 円491.00 (19.2% below fair value)
Industry Position: 98.9% below the Healthcare Providers & Services median (#418 of 681)
No single metric tells the full story. See the TSE:2796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on the prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.
50GF Score
Get the complete analysis for TSE:2796
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2796 has been successfully added to your 
